Gene · 1725
Papers1,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a two-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus artesunate monotherapy among asymptomatic children 3-5 years of age in Zambia. | BMC Infect Dis | 2025 | 41219832 | PubTator, text mining | PubMed |
| Prevalence of Molecular Markers of Resistance to Antimalarial Drugs Three Years After Perennial Malaria Chemoprevention in Sierra Leone. | Gates Open Res | 2025 | 41080970 | PubTator, text mining | PubMed |
| Molecular analysis of DHFR and DHPS gene mutations in Plasmodium cynomolgi from humans and macaques in Southeast Asia. | Parasite | 2025 | 41021794 | PubTator, text mining | PubMed |
| eIF5A and hypusination-related disorders: literature review and case report of DOHH-related encephalopathy. | J Neurodev Disord | 2025 | 40883692 | PubTator, text mining | PubMed |
| A novel intron variant is associated with emerging pfdhps mutant haplotypes in West and Central African Plasmodium falciparum. | Int J Parasitol Drugs Drug Resist | 2025 | 40882319 | PubTator, text mining | PubMed |
| In silico and in vitro antibacterial evaluation of eight Anatolian Salvia species with chemical profiling by LC-HRMS. | Sci Rep | 2025 | 40858706 | PubTator, text mining | PubMed |
| Combatting resistance: natural products as tools to drive the discovery of untapped antibiotic targets. | Chem Commun (Camb) | 2025 | 40844298 | PubTator, text mining | PubMed |
| Benchmarking and optimization of methods for the detection of identity-by-descent in high-recombining Plasmodium falciparum genomes. | Elife | 2025 | 40827852 | PubTator, text mining | PubMed |
| Oncogenic Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus on Cell Metabolism and Cell Transformation. | J Med Virol | 2025 | 40827105 | PubTator, text mining | PubMed |
| Prevalence of Plasmodium falciparum parasites harbouring chloroquine-resistant but not artemisinin-resistant alleles in Busia County, Western Kenya. | Malar J | 2025 | 40739505 | PubTator, text mining | PubMed |
| Rising prevalence of Plasmodium falciparum Artemisinin partial resistance mutations in Ethiopia. | Commun Med (Lond) | 2025 | 40681807 | PubTator, text mining | PubMed |
The impact of sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive treatment for the prevention of malaria in pregnancy in Africa: an updated systematic review and meta-analysis. | Lancet Infect Dis | 2025 | 40675171 | PubTator, text mining | PubMed |
| A silent sulfonamide-resistant microbial world: The curious case of missing DHPS in candidate phyla radiation. | J Glob Antimicrob Resist | 2025 | 40639500 | PubTator, text mining | PubMed |
| Repurposing sulfonamide-scaffolds for enhanced and sustainable malaria therapy. | Future Med Chem | 2025 | 40577062 | PubTator, text mining | PubMed |
| Collection, preparation, and biobanking of clinical specimens for analysis in polyaminopathies. | Methods Enzymol | 2025 | 40382145 | PubTator, text mining | PubMed |
| Genetic analyses of Myc and hypusine circuits in tumorigenesis. | Methods Enzymol | 2025 | 40382132 | PubTator, text mining | PubMed |
| Synthesis, structural studies, and inhibitory potential of selected sulfonamide analogues: insights from in silico and in vitro analyses. | EXCLI J | 2025 | 40376437 | PubTator, text mining | PubMed |
| Impact of dhps mutations on sulfadoxine-pyrimethamine protective efficacy and implications for malaria chemoprevention. | Nat Commun | 2025 | 40341172 | PubTator, text mining | PubMed |
| Synthesis and evaluation of antibacterial activity of new thieno[2,3-d]pyrimidine hybrid compounds targeting dihydropteroate synthase to combat antibiotic resistance. | Bioorg Chem | 2025 | 40318508 | PubTator, text mining | PubMed |
| Mapping dihydropteroate synthase evolvability through identification of a novel evolutionarily critical substructure. | Int J Biol Macromol | 2025 | 40254194 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1725/papers?page=3